{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:51:15Z","timestamp":1790394675474,"version":"4.1.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Animal models have been highly informative for understanding the characteristics, onset, and progression of cystic fibrosis (CF) lung disease. In particular, the CFTR\u2212\/\u2212 rat has revealed insights into the airway mucus defect characteristic of CF but does not replicate a human-relevant CFTR (cystic fibrosis transmembrane conductance regulator) variant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We hypothesized that a rat expressing a humanized version of CFTR and harboring the ivacaftor-sensitive variant G551D could be used to test the impact of CFTR modulators on pathophysiologic development and correction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we describe a humanized-CFTR rat expressing the G551D variant obtained by zinc finger nuclease editing of a human complementary DNA superexon, spanning exon 2\u201327, with a 5\u2032 insertion site into the rat gene just beyond intron 1. This targeted insertion takes advantage of the endogenous rat promoter, resulting in appropriate expression compared with wild-type animals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>The bioelectric phenotype of the epithelia recapitulates the expected absence of CFTR activity, which was restored with ivacaftor. Large airway defects, including depleted airway surface liquid and periciliary layers, delayed mucus transport rates, and increased mucus viscosity, were normalized after the administration of ivacaftor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This model is useful to understand the mechanisms of disease and the extent of pathology reversal with CFTR modulators.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.202002-0369oc","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T09:39:25Z","timestamp":1593077965000},"page":"1271-1282","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":50,"title":["Ivacaftor Reverses Airway Mucus Abnormalities in a Rat Model Harboring a Humanized G551D-CFTR"],"prefix":"10.1093","volume":"202","author":[{"given":"Susan E.","family":"Birket","sequence":"first","affiliation":[{"name":"Department of Medicine"},{"name":"Cystic Fibrosis Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy M.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney M.","family":"Fernandez-Petty","sequence":"additional","affiliation":[{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Henderson","sequence":"additional","affiliation":[{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley M.","family":"Oden","sequence":"additional","affiliation":[{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiPing","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wen","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianwu","family":"Fu","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Research Center, and"},{"name":"Cell, Developmental, and Integrated Biology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Chambers","sequence":"additional","affiliation":[{"name":"Horizon Discovery Group PLC, St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Fields","sequence":"additional","affiliation":[{"name":"Horizon Discovery Group PLC, St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gojun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Horizon Discovery Group PLC, St. Louis, Missouri; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo J.","family":"Tearney","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Sorscher","sequence":"additional","affiliation":[{"name":"Cell, Developmental, and Integrated Biology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Rowe","sequence":"additional","affiliation":[{"name":"Department of Medicine"},{"name":"Cystic Fibrosis Research Center, and"},{"name":"Cell, Developmental, and Integrated Biology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,1]]},"reference":[{"key":"2026030321533134600_bib1","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N Engl J Med"},{"key":"2026030321533134600_bib2","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1073\/pnas.91.12.5340","article-title":"Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator","volume":"91","author":"Poulsen","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321533134600_bib3","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.lpm.2017.04.010","article-title":"The diagnosis of cystic fibrosis","volume":"46","author":"De Boeck","year":"2017","journal-title":"Presse Med"},{"key":"2026030321533134600_bib4","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/ppul.23233","article-title":"Personalized medicine for cystic fibrosis: establishing human model systems","volume":"50","author":"Mou","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"2026030321533134600_bib5","first-page":"S28","article-title":"Animal and model systems for studying cystic fibrosis","volume-title":"J Cyst Fibros","author":"Rosen","year":"2018"},{"key":"2026030321533134600_bib6","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321533134600_bib7","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321533134600_bib8","doi-asserted-by":"crossref","first-page":"9776","DOI":"10.1021\/jm5012808","article-title":"Discovery of N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide (VX-770, ivacaftor), a potent and orally bioavailable CFTR potentiator","volume":"57","author":"Hadida","year":"2014","journal-title":"J Med Chem"},{"key":"2026030321533134600_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.257.5073.1083","article-title":"An animal model for cystic fibrosis made by gene targeting","volume":"257","author":"Snouwaert","year":"1992","journal-title":"Science"},{"key":"2026030321533134600_bib10","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1126\/science.1163600","article-title":"Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs","volume":"321","author":"Rogers","year":"2008","journal-title":"Science"},{"key":"2026030321533134600_bib11","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI43052","article-title":"Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis","volume":"120","author":"Sun","year":"2010","journal-title":"J Clin Invest"},{"key":"2026030321533134600_bib12","doi-asserted-by":"crossref","first-page":"e123529","DOI":"10.1172\/jci.insight.123529","article-title":"A sheep model of cystic fibrosis generated by CRISPR\/Cas9 disruption of the CFTR gene","volume":"3","author":"Fan","year":"2018","journal-title":"JCI Insight"},{"key":"2026030321533134600_bib13","doi-asserted-by":"crossref","first-page":"e0199573","DOI":"10.1371\/journal.pone.0199573","article-title":"A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies","volume":"13","author":"McHugh","year":"2018","journal-title":"PLoS One"},{"key":"2026030321533134600_bib14","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1038\/s41598-019-48105-4","article-title":"A BAC transgene expressing human CFTR under control of its regulatory elements rescues Cftr knockout mice","volume":"9","author":"Gawenis","year":"2019","journal-title":"Sci Rep"},{"key":"2026030321533134600_bib15","doi-asserted-by":"crossref","first-page":"e91253","DOI":"10.1371\/journal.pone.0091253","article-title":"Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats","volume":"9","author":"Tuggle","year":"2014","journal-title":"PLoS One"},{"key":"2026030321533134600_bib16","doi-asserted-by":"crossref","first-page":"e0188497","DOI":"10.1371\/journal.pone.0188497","article-title":"Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat","volume":"12","author":"Stalvey","year":"2017","journal-title":"PLoS One"},{"key":"2026030321533134600_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mod.2018.10.002","article-title":"Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats","volume":"155","author":"Plyler","year":"2019","journal-title":"Mech Dev"},{"key":"2026030321533134600_bib18","doi-asserted-by":"crossref","first-page":"e97199","DOI":"10.1172\/jci.insight.97199","article-title":"Development of an airway mucus defect in the cystic fibrosis rat","volume":"3","author":"Birket","year":"2018","journal-title":"JCI Insight"},{"key":"2026030321533134600_bib19","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N Engl J Med"},{"key":"2026030321533134600_bib20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"2026030321533134600_bib21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cid\/ciu944","article-title":"Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor","volume":"60","author":"Heltshe","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026030321533134600_bib22","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321533134600_bib23","doi-asserted-by":"crossref","first-page":"e54473","DOI":"10.1371\/journal.pone.0054473","article-title":"Method for quantitative study of airway functional microanatomy using micro-optical coherence tomography","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"2026030321533134600_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/rccm.201404-0670OC","article-title":"A functional anatomic defect of the cystic fibrosis airway","volume":"190","author":"Birket","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321533134600_bib25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bpj.2016.07.020","article-title":"Particle-tracking microrheology using micro-optical coherence tomography","volume":"111","author":"Chu","year":"2016","journal-title":"Biophys J"},{"key":"2026030321533134600_bib26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1177\/00220345960750041101","article-title":"Abnormal enamel development in a cystic fibrosis transgenic mouse model","volume":"75","author":"Wright","year":"1996","journal-title":"J Dent Res"},{"key":"2026030321533134600_bib27","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3389\/fphar.2018.01475","article-title":"Animal models in the pathophysiology of cystic fibrosis","volume":"9","author":"Semaniakou","year":"2019","journal-title":"Front Pharmacol"},{"key":"2026030321533134600_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1164\/rccm.201805-0827LE","article-title":"Maternal smoking induces acquired CFTR dysfunction in neonatal rats","volume":"198","author":"McCormick","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321533134600_bib29","doi-asserted-by":"crossref","first-page":"L928","DOI":"10.1152\/ajplung.00395.2015","article-title":"Combination therapy with cystic fibrosis transmembrane conductance regulator modulators augment the airway functional microanatomy","volume":"310","author":"Birket","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026030321533134600_bib30","doi-asserted-by":"crossref","first-page":"e66955","DOI":"10.1371\/journal.pone.0066955","article-title":"Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation","volume":"8","author":"Rowe","year":"2013","journal-title":"PLoS One"},{"key":"2026030321533134600_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321533134600_bib32","doi-asserted-by":"crossref","first-page":"e125954","DOI":"10.1172\/jci.insight.125954","article-title":"A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus","volume":"4","author":"Fernandez-Petty","year":"2019","journal-title":"JCI Insight"},{"key":"2026030321533134600_bib33","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1073\/pnas.1323633111","article-title":"Assessing mucociliary transport of single particles in vivo shows variable speed and preference for the ventral trachea in newborn pigs","volume":"111","author":"Hoegger","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321533134600_bib34","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1255825","article-title":"Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis","volume":"345","author":"Hoegger","year":"2014","journal-title":"Science"},{"key":"2026030321533134600_bib35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI83922","article-title":"Acidic pH increases airway surface liquid viscosity in cystic fibrosis","volume":"126","author":"Tang","year":"2016","journal-title":"J Clin Invest"},{"key":"2026030321533134600_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"key":"2026030321533134600_bib37","doi-asserted-by":"crossref","first-page":"18131","DOI":"10.1073\/pnas.0606428103","article-title":"A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms","volume":"103","author":"Matsui","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030321533134600_bib38","doi-asserted-by":"crossref","first-page":"eaau7531","DOI":"10.1126\/scitranslmed.aau7531","article-title":"In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis","volume":"11","author":"Sun","year":"2019","journal-title":"Sci Transl Med"},{"key":"2026030321533134600_bib39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MCP.0b013e32834b14c9","article-title":"New animal models of cystic fibrosis: what are they teaching us?","volume":"17","author":"Keiser","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"2026030321533134600_bib40","doi-asserted-by":"crossref","first-page":"29ra31","DOI":"10.1126\/scitranslmed.3000928","article-title":"Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth","volume":"2","author":"Stoltz","year":"2010","journal-title":"Sci Transl Med"},{"key":"2026030321533134600_bib41","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201708-1616OC","article-title":"Infection is not required for mucoinflammatory lung disease in CFTR-knockout ferrets","volume":"197","author":"Rosen","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321533134600_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.cell.2010.11.029","article-title":"Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia","volume":"143","author":"Chen","year":"2010","journal-title":"Cell"},{"key":"2026030321533134600_bib43","doi-asserted-by":"crossref","first-page":"C1061","DOI":"10.1152\/ajpcell.1994.266.4.C1061","article-title":"Mechanism of sodium hyperabsorption in cultured cystic fibrosis nasal epithelium: a patch-clamp study","volume":"266","author":"Chinet","year":"1994","journal-title":"Am J Physiol"},{"key":"2026030321533134600_bib44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ppul.1144","article-title":"Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis","volume":"32","author":"Rosenfeld","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"2026030321533134600_bib45","first-page":"10","article-title":"Gene editing & stem cells","volume-title":"J Cyst Fibros","author":"Harrison","year":"2018"},{"key":"2026030321533134600_bib46","doi-asserted-by":"crossref","first-page":"e0161072","DOI":"10.1371\/journal.pone.0161072","article-title":"Targeted integration of a super-exon into the CFTR locus leads to functional correction of a cystic fibrosis cell line model","volume":"11","author":"Bednarski","year":"2016","journal-title":"PLoS One"},{"key":"2026030321533134600_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/BJ20120693","article-title":"Transcriptional networks driving enhancer function in the CFTR gene","volume":"446","author":"Kerschner","year":"2012","journal-title":"Biochem J"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/9\/1271\/67177380\/ajrccm_202_9_1271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/9\/1271\/67177380\/ajrccm_202_9_1271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:53:43Z","timestamp":1772592823000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/202\/9\/1271\/8495483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,11,1]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202002-0369oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,11,1]]},"assertion":[{"value":"2020-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}